GlassScriptPhysician profile
Kerry Welch
NPI 1346291796
$1,861.00
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $700 · 2021: $603 · 2022: $185.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $282.11 | 2019-2022 | |
| Abbvie INC. | $208.93 | 2021-2022 | |
| Lilly USA, LLC | $207.88 | 2019-2022 | |
| Allergan, INC. | $199.02 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $187.87 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $143.32 | 2019-2021 | |
| Pfizer INC. | $70.47 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $65.25 | 2020-2021 | |
| Mannkind Corporation | $45.81 | 2020-2021 | |
| Eisai INC. | $44.68 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.44 | 2019-2020 | |
| Daiichi Sankyo INC. | $37.23 | 2020-2021 | |
| Indivior INC. | $35.60 | 2019 | |
| Merck Sharp & Dohme LLC | $32.55 | 2021-2022 | |
| Novo Nordisk INC | $32.47 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $28.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.05 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $26.11 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.39 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.97 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.85 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.03 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.98 | 2019 | |
| Dynavax Technologies Corporation | $13.64 | 2019 | |
| Bausch Health US, LLC | $12.12 | 2022 | |
| Glaxosmithkline, LLC. | $12.01 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.90 | 2019 | |
| Organon LLC | $2.21 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.